A novel HISFME method uses a TSIL-sertraline chelate and NaBF 4 to trigger in situ phase separation, enabling efficient, selective, and eco-friendly extraction of trace pharmaceuticals without dispersive solvents or complex equipment.
Hosseini et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: